UnitedHealth Group Loss on sale of subsidiaries decreased by 102.4% to -$83.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 315.0%, from -$20.00M to -$83.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates significant divestiture activity or impairment of assets being sold, which may signal a strategic pivot or a cleanup of underperforming business units.
This metric represents the financial loss incurred when a company disposes of a business unit, division, or subsidiary....
Commonly reported as a non-operating or special item by large conglomerates and diversified healthcare firms during portfolio optimization.
is_loss_on_sale_of_subsidiaries| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$7.09B | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +82.7% | +98.4% | +100.0% | — | -173.3% | -102.4% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | +99.8% | +96.7% | -315.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.